Lilly(Eli) & Co

NYSE:LLY   12:25:27 PM EDT
-2.08 (-1.42%)

Lilly Announces Arrangement For Supply Of Potential COVID-19 Antibody Therapy For Low- And Middle-Income Countries

Published: 10/08/2020 11:06 GMT
Eli Lilly and Co (LLY) - Lilly Announces Arrangement for Supply of Potential Covid-19 Antibody Therapy for Low- and Middle-income Countries.
Eli Lilly and Co - Commercial Manufacturing Will Commence in April 2021 at Fujifilm Diosynth Biotechnologies Facility in Denmark.
Eli Lilly - to Make Certain Volumes of Its Antibody Therapeutic Manufactured in Other Facilities Available to Lower-income Countries Prior to Apr 2021.
Eli Lilly - Co, Bill & Melinda Gates Foundation to Facilitate Access to Future Therapeutic Antibodies for Treatment of Covid-19 to Benefit Low- and Middle-income Countries.
Eli Lilly and Co - Lilly, Collaboration Partners Will Continue to Be Responsible for Research and Development of Product.
Eli Lilly - Lilly's Collaborators Have Agreed to Waive Their Royalties on Lilly Therapeutic Antibodies Distributed in Low- and Middle-income Countries.